Skip to main content
OpenTrials

Clinical trial condition

Refractory Malignant Solid Neoplasm

Explore clinical trials studying Refractory Malignant Solid Neoplasm. Study availability and eligibility vary by location and protocol.

91 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Refractory Malignant Solid Neoplasm trial results

Recruiting

AOH1996 for the Treatment of Refractory Solid Tumors

NCT05227326

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +39 more
Locations
  • Honor Health Research and Innovation Institute Scottsdale, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope at Long Beach Elm Long Beach, California, United States
View Trial Details
Recruiting

Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer

NCT05111561

Conditions
Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Boston Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Texas Medical Branch Galveston, Texas, United States
  • UT MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

NCT05053971

Conditions
Advanced Malignant Solid Neoplasm, Digestive System Diseases, Digestive System Neoplasms, +14 more
Locations
  • Yale University New Haven, Connecticut, United States
  • UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details
Recruiting

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

NCT04901702

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +55 more
Locations
  • Lucille Packard Children's Hospital Stanford Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta/Emory University School of Medicine Atlanta, Georgia, United States
View Trial Details
Recruiting

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NCT04851119

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +90 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 21 locations
View Trial Details
Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

NCT04870944

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +31 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 35 locations
View Trial Details
Recruiting

Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma

NCT06620302

Conditions
Childhood Fibrolamellar Carcinoma, Fibrolamellar hepatocellular carcinoma, Recurrent Childhood Fibrolamellar Carcinoma, +7 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 21 locations
View Trial Details

Related conditions